Amalgamated Bank’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-9,437
| Closed | -$1.43M | – | 3010 |
|
|
2022
Q3 | $1.43M | Buy |
9,437
+245
| +3% | +$37K | 0.01% | 971 |
|
|
2022
Q2 | $1.34M | Buy |
9,192
+863
| +10% | +$126K | 0.01% | 1031 |
|
|
2022
Q1 | $988K | Sell |
8,329
-624
| -7% | -$74K | 0.01% | 1204 |
|
|
2021
Q4 | $1.23M | Sell |
8,953
-88
| -1% | -$12.1K | 0.01% | 1143 |
|
|
2021
Q3 | $1.26M | Sell |
9,041
-306
| -3% | -$42.5K | 0.01% | 1136 |
|
|
2021
Q2 | $907K | Buy |
9,347
+2,497
| +36% | +$242K | 0.01% | 1339 |
|
|
2021
Q1 | $468K | Sell |
6,850
-668
| -9% | -$45.6K | 0.02% | 1022 |
|
|
2020
Q4 | $644K | Buy |
7,518
+40
| +0.5% | +$3.43K | 0.02% | 818 |
|
|
2020
Q3 | $486K | Sell |
7,478
-71
| -0.9% | -$4.61K | 0.02% | 850 |
|
|
2020
Q2 | $552K | Buy |
7,549
+182
| +2% | +$13.3K | 0.03% | 780 |
|
|
2020
Q1 | $251K | Buy |
7,367
+198
| +3% | +$6.75K | 0.01% | 1238 |
|
|
2019
Q4 | $390K | Buy |
7,169
+615
| +9% | +$33.5K | 0.01% | 1253 |
|
|
2019
Q3 | $273K | Buy |
6,554
+588
| +10% | +$24.5K | 0.01% | 1369 |
|
|
2019
Q2 | $261K | Buy |
5,966
+1,252
| +27% | +$54.8K | 0.01% | 1436 |
|
|
2019
Q1 | $243K | Buy |
+4,714
| New | +$243K | 0.01% | 1397 |
|